Latest Conference Articles

As part of the overall picture of multiple sclerosis treatment optic neuritis is one of the early stages of the condition. The studies looked at sodium channels that show promise for future multiple sclerosis patients even if it is not in the field.

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

In many medical school programs students might only get a few weeks of training in dermatology which likely will not cover all the conditions they will see, particularly working in hospitals. From fellowships to online learning there is a concerted effort underway to change that trend.

While hospitals across the country have begun adding dermatologists to their staff it has not become common practice across the field. As a result care of the patients can vary and telemedicine has become an increasingly popular option in diagnosis.

In hospitals across the country patients are being admitted with conditions that can only be treated by specially trained dermatologists while others are developing issues during hospitalization. How quickly and how well they are treated can make a significant difference in patient care.

Sometimes even the most routine appearing patients can have results on their EKG that that can catch even the most veteran cardiologists off guard. This can be especially true for people who have had relatives suffer an unexpected cardiac fatality.

After diagnosing a patient complaining of dizziness it falls to the doctors seeing them to find the proper course of treatment. There are also efforts underway to develop new methods of treatment including modern devices that could be used in the future.

Many patients who come to the emergency department are seen and receive any number of diagnoses based on their symptoms and the length of time of their issues. How those symptoms are addressed can make a significant difference in their overall care.

There have been demonstrated benefits to implementing antimicrobial stewardship programs in medical facilities of all sizes. While they have become more popular, there are several factors that need to be considered before making that move.

Antimicrobial stewardship programs are becoming more popular across the country, particularly in larger facilities. A recent push has worked to extend that effort into small hospitals and outpatient facilities as well.

When a patient goes to see their primary care physician they often do so with the hopes of getting the care they need with their doctor. Whether they need to be seen by a specialist is often a more subjective decision by their healthcare provider.

There is no shortage of treatments available for the treatment of type 2 diabetes, but a new medication could change the way some patients manage their disease and could have even further reaching effects in the future.

Patients diagnosed with Parkinson's disease face a wide range of physical ailments with their condition. One of the lesser addressed areas is the psychological aspects they face as well. Therapeutic alternatives are being developed to help treat psychosis in this particular patient group.

Research has shown how important sleep can be for a person's health. For patients with insomnia every little bit helps and medications have been developed for this specific condition with some having more serious side effects than others.

When doctors are considering medications to prescribe to patients there are several factors they need to consider, not the least of which is cost.

Rivaroxaban, also known as Xarelto has been on the market for many years but was recently approved for use in patients with DVT and pulmonary embolism.

With primary care physicians treating such a broad spectrum of conditions they also have a number of medications they can prescribe to help their patients. While some of these are more beneficial than others it is important to consider which might be more effective for patients.

Hyperkalemia can be a significant diagnosis for patients and finding the right treatment can have a great impact on their quality of life. New medications could help in their daily care.

Hypertension is a common diagnosis in patients and can often require patients to visit their doctors on a regular basis. A new approach to treatment could mean fewer trips for patients while providing a high level of care at the same time.

Medications in general can take a long time to develop. Depending on the condition they treat that process can be even longer as more questions have to be answered before they can be introduced to the field. This is particularly true of multiple sclerosis treatments.

As a treatment for multiple sclerosis teriflunomide has shown benefits over a long development period and has proven effective in the treatment of patients with the relapsing-remitting form of the condition.

For as many drugs and therapies as there are for multiple sclerosis some are more aggressive than others. Alemtuzumab's approach is more on the aggressive end of the spectrum.

Epilepsy is a well known condition both in the medical community and in the general public. Despite that there is still a considerable amount of misinformation that can affect a person's willingness to seek treatment and know what to expect during the process.

Using the new guidelines set forth by the American Academy of Neurology should help doctors and patients understand how best to proceed as more is learned about the affects of first seizures and factors that could contribute to future occurrences.

When a patient suffers their first seizure their initial reaction may be to seek immediate medical and pharmaceutical care to ensure there are no subsequent events. Doctors themselves may look for quick fixes rather than longer lasting remedies.

Patients who suffer their first seizure are expected to have several questions. In some instances, one question may be why their doctor is waiting until a second seizure to begin treatment. A new guideline from the American Academy of Neurology looked to answer that question for doctors and patients alike.

As more is learned about the diagnosis and treatment of CIDP the medical community is also learning how best to work with patients with the condition.

Sometimes symptoms of CIDP can closely resemble those of other conditions. In light of this it is important for doctors to take a closer look to ensure a proper diagnosis is made.

Doctors treating patients with pediatric multiple sclerosis often turn to the same treatments as adult patients. While there are some unique characteristics and more work is being done in the field, these seem to give the best hope of maintaining a high quality of life for the young patients.

Getting a proper diagnosis for pediatric multiple sclerosis is not an easy task and requires a partnership between doctors, patients and their families.